Impact of interstitial lung abnormality on survival after adjuvant durvalumab with chemoradiotherapy for locally advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Impact of interstitial lung abnormality on survival after adjuvant durvalumab with chemoradiotherapy for locally advanced non-small cell lung cancer

Published:2023-03 Issue: Volume:180 Page:109454
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Kashihara Tairo,Nakayama Yuko,Okuma Kae,Takahashi Ayaka,Kaneda Tomoya,Katagiri Mika,Nakayama Hiroki,Kubo Yuko,Ito Kimiteru,Nakamura Satoshi,Takahashi Kana,Inaba Koji,Murakami Naoya,Saito Tetsuo,Okamoto Hiroyuki,Itami Jun,Kusumoto Masahiko,Ohe Yuichiro,Igaki Hiroshi

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference37 articles.

1. Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer;Antonia;N Engl J Med,2017

2. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC;Antonia;N Engl J Med,2018

3. Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC;Gray;J Thorac Oncol,2020

4. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer;Spigel;J Clin Oncol,2022

5. Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study;Desilets;Eur J Cancer,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis;PLOS ONE;2024-06-12

2. Multiple drugs;Reactions Weekly;2024-05-18

3. Prognostic impact of interstitial lung abnormalities in lung cancer: a systematic review and meta-analysis;Frontiers in Oncology;2024-05-10

4. Prevalence and prognostic meaning of interstitial lung abnormalities in remote CT scans of patients with interstitial lung disease treated with antifibrotic therapy;Radiología (English Edition);2024-04

5. Prevalencia y significado pronóstico de las alteraciones pulmonares intersticiales precoces en TC de pacientes diagnosticados de enfermedad pulmonar intersticial tratados con antifibróticos;Radiología;2023-05